Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Bristol-Myers Squi

Read full story on benzinga.com
Share
Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Bristol-Myers Squi
AI disclosure

Summary

Bristol Myers Squibb unveiled a multibillion-dollar partnership with Hengrui Pharma spanning 13 drug programs.

Original reporting

Open original source

Related coverage

Read full article on benzinga.com